IGM Biosciences financials at a glance

+ Portfolio

The revenue of IGM Biosciences is reported as 0.00236 billion Dollars in the fiscal year 2023. The earnings were -4.94 Dollars per share in 2023, which was 7.91 lower than 2021. And about -0.205 billion Dollars are reported as free cash flow in the financials of IGM Biosciences 2023. No dividends were paid to the shareholders of the IGM Biosciences stock NasdaqGS:IGMS in the financial year 2023.

$1.07M

Revenue

$-5.32

Earnings Per Share

0.00%

Gross Margin %

$-16.06M

Free Cash Flow

Revenue

1.07

Earnings Per Share

-5.32

Gross Margin %

0.00

Free Cash Flow

-16.06

Financials

Year	Year	TTM	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$1.07M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-4.92	$-5.32	$-4.93	$-2.65	$-4.80	$-0.46
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	0	0	0	0
Sha.	Shares	N/AM	43.18M	32.51M	32.01M	30.56M	0.44M
OCF	Operating Cash Flow	N/A	$-5.85M	$-,124.34M	$-67.30M	$-45.12M	$0.00M
FCF	Free Cash Flow	N/A	$-16.06M	$-,137.58M	$-84.81M	$-47.45M	$0.00M
FCFS	Free Cash Flow Per Share	$-4.04	$-0.39	$-4.11	$-2.76	$-5.28	$0.00

IGM Biosciences financials at a glance

Financials

Discover